Patent Application Titled "Compositions And Methods Relating To The Treatment Of Diseases" Published Online (USPTO 20240124545).

The patent application titled "Compositions And Methods Relating To The Treatment Of Diseases" by William Stimson discusses the use of interferon-alpha (IFN-alpha) in treating viral conditions such as respiratory, gastrointestinal, and neurological viral diseases. The inventor proposes a variant of interferon alpha 14, called HYBRID 2, as a potential treatment for viral infections. Experiments have shown the anti-viral effects of HYBRID 2 against various viruses, including SARS-CoV-1, SARS-CoV-2, HIV, RSV, and HSV1. The patent application suggests that HYBRID 2 could be administered through direct injection or sublingually, and low doses may be effective in reducing viral activity. The application also highlights the potential utility of HYBRID 2 in the treatment and prevention of viral infections, including a wide range of viruses. For more information, please refer to the full patent. [Extracted from the article]